Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

stz-analyst-rating-maintained:-four-firms-raise-price-targets-april-10

STZ Analyst Rating Maintained: Four Firms Raise Price Targets April 10

Apr 11, 2026

Wall Street’s consensus on Constellation Brands remains steady even as multiple analysts boost their price targets. On April…

Read more
bntx-analyst-rating-maintained-at-overweight-by-morgan-stanley

BNTX Analyst Rating Maintained at Overweight by Morgan Stanley

Apr 11, 2026

Wall Street’s confidence in BioNTech SE remains steady. Morgan Stanley maintained its BNTX analyst rating at Overweight on…

Read more
top-research-reports-for-bank-of-america,-ge-aerospace-&-t-mobile

Top Research Reports for Bank of America, GE Aerospace & T-Mobile

Apr 11, 2026

Mark Vickery   Published on April 10, 2026 | BAC GE EQIX SNDK ALC TMUS WLFC Trades from $3…

Read more
raymond-james-initiates-milestone-pharmaceuticals-stock-coverage-with-strong-buy

Raymond James initiates Milestone Pharmaceuticals stock coverage with Strong Buy

Apr 11, 2026

Raymond James initiates Milestone Pharmaceuticals stock coverage with Strong Buy

Read more
eli-lilly-(lly)-analyst-ratings-data:-april-2026-updates

Eli Lilly (LLY) Analyst Ratings Data: April 2026 Updates

Apr 11, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
lbrx-upgraded-to-buy-by-craig-hallum-on-april-10,-2026

LBRX Upgraded to Buy by Craig-Hallum on April 10, 2026

Apr 11, 2026

Wall Street just gave LB Pharmaceuticals Inc Common Stock (LBRX) a fresh vote of confidence. Craig-Hallum initiated coverage…

Read more
cbz:-today’s-analyst-rating-data-reveals-coverage-initiated

CBZ: Today’s Analyst Rating Data Reveals Coverage Initiated

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
today’s-analyst-ratings-for-pkg:-ubs-lowers-price-target-to-$225.00

Today’s Analyst Ratings for PKG: UBS Lowers Price Target to $225.00

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
today’s-analyst-ratings-update-for-ip:-international-paper

Today’s Analyst Ratings Update for IP: International Paper

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
today’s-analyst-ratings-for-mstr:-key-updates-and-price-adjustments

Today’s Analyst Ratings for MSTR: Key Updates and Price Adjustments

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
nebius-(nbis)-stock-hits-all-time-high-after-acquisition-talks-and-new-analyst-coverage

Nebius (NBIS) Stock Hits All-Time High After Acquisition Talks and New Analyst Coverage

Apr 10, 2026

TLDR Nebius Group (NBIS) hit an all-time high of $141.14 this week, up 21.1% from the prior Friday’s…

Read more
eli-lilly-(lly)-analyst-ratings-data:-april-2026-updates

Eli Lilly (LLY) Analyst Ratings Data: April 2026 Updates

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 61
  6. 62
  7. 63
  8. 64
  9. 65
  10. 66
  11. 67
  12. ...
  13. 452
  14. »

Posts pagination

Newer posts Page 1 … Page 64 … Page 452 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.